May 24, 2025
Trending Now
  •    Houston Methodist Opens New State-Of-The-Art Patient Tower In Texas Medical Center...

  •    MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia...

  •    NuVasive and Siemens Healthineers partner to transform spine surgery...

  •    Boston Scientific Announces Agreement to Acquire VENITI, Inc....

  •    CHA-Hollywood Presbyterian Medical Center at the Forefront of Robotic Surgical Technology...

  •    Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease...

  •    Welltower And ProMedica Complete Acquisition Of Quality Care Properties And HCR ManorCare For $4.4 Billion...

  •    Perflow Medical Announces the First Clinical Use of the Cascade Dynamic Non-Occlusive Remodeling Net...

  • About
  • Advertise
  • Subscribe
  • Contact

Global Healthcare Review

  • Home
  • Region
    • Africa & Middle East
    • Asia
    • Europe
    • North America
    • South America
  • News
  • Press Releases
  • White Papers
  • Industry Reports
  • Case Studies
  • Projects
  • Research Insights
12 New Articles
  • August 12, 2018 Houston Methodist Opens New State-Of-The-Art Patient Tower In Texas Medical Center
  • August 12, 2018 MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
  • August 12, 2018 NuVasive and Siemens Healthineers partner to transform spine surgery
  • August 9, 2018 Boston Scientific Announces Agreement to Acquire VENITI, Inc.
  • July 29, 2018 CHA-Hollywood Presbyterian Medical Center at the Forefront of Robotic Surgical Technology
  • July 29, 2018 Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
  • July 29, 2018 Welltower And ProMedica Complete Acquisition Of Quality Care Properties And HCR ManorCare For $4.4 Billion
  • July 25, 2018 Perflow Medical Announces the First Clinical Use of the Cascade Dynamic Non-Occlusive Remodeling Net
  • July 25, 2018 FDA approves the first nanotechnology Peek device for spinal interbody fusion
  • July 25, 2018 Ibex Medical Analytics and UPMC Join Forces for Advancing AI-based Prostate Cancer Diagnostics
  • July 25, 2018 PGDx elio Plasma Resolve Receives Breakthrough Device Designation from FDA
  • July 24, 2018 Karmanos Expands Cancer Network with Newest Location at McLaren Oakland
Home News (page 20)

News

Genesis Healthcare, Pioneer in Genetic Health Testing, Announces 1.4 Bil. Yen New Share Issue to Rakuten

By Healthcare Review
August 20, 2017
in :  Asia, News

Genesis Healthcare Co. has announced the completion of a new share issue worth 1.4 billion yen for allotment to Rakuten Inc. Furthermore, Rakuten’s Chairman and CEO will join Genesis Healthcare’s Board of Directors as an External Board Director. As a result of the new stock offering, Genesis Healthcare’s capital has increased to 2.1 billion yen, one of the largest paid-in-capital …

Read More

Prollenium Medical Technologies Inc. announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler

By Healthcare Review
August 18, 2017
in :  News, North America

Prollenium Medical Technologies Inc. announced its United States (U.S.) Food and Drug Administration (FDA) approval for its cross-linked hyaluronic acid dermal filler. Ario Khoshbin, Founder and CEO, stated “This is definitely one of our proudest moments as an organization. FDA approval is a culmination of efforts from every single member of our team. As an organization, we have been working …

Read More

Amgen And Humana Partner For Improved Health Outcomes And Efficiency

By Healthcare Review
August 17, 2017
in :  News, North America

Two of the nation’s leading health organizations, health and well-being company Humana Inc. (NYSE: HUM) and biotechnology company Amgen, have teamed up to identify opportunities to improve health outcomes and improve efficiency by unlocking new insights from the real world health care experiences of Humana’s 13 million members. In the collaboration agreement between Amgen and Humana, six projects are currently …

Read More

Vituro Health Expands Into Arkansas, Providing The Latest In Precision Prostate Cancer Care

By Healthcare Review
August 17, 2017
in :  Europe, News

Vituro Health and Arkansas Urology, LUGPA member and the largest urology practice in the state, partnered to offer patients in Arkansas and surrounding states the latest, most innovative technologies in prostate cancer treatment and precision disease management. In conjunction with Vituro Health, Arkansas Urology will offer patients advanced diagnostics, navigation services, and HIFU (High Intensity Focused Ultrasound) therapy. “Arkansas Urology …

Read More

NextGen Healthcare Completes Acquisition of EagleDream Health Inc.

By Healthcare Review
August 16, 2017
in :  News, North America

NextGen Healthcare Information Systems announced the completion of the previously announced acquisition of EagleDream Health Inc., a software analytics solutions company. Headquartered in Rochester, N.Y., EagleDream Health is a cloud-based analytics company that drives meaningful insight across clinical, financial and administrative data to optimize practice performance. “We’re very excited to conclude our acquisition of EagleDream Health, which represents a significant …

Read More

Cardinal Health Completes Acquisition of Medtronic’s Patient Recovery Business

By Healthcare Review
July 30, 2017
in :  News, North America

Cardinal Health announced that it has completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1 billion. The acquisition was funded with a combination of $4.5 billion in new senior unsecured notes, existing cash and borrowings under our existing credit arrangements. “This business provides our customers with more product offerings and includes some well-established …

Read More

bioMérieux Receives FDA Clearance for Expanded Pathogen Identification Capability on VITEK® MS

By Healthcare Review
July 30, 2017
in :  Europe, News

bioMérieux, a world leader in the field of in vitro diagnostics announced that VITEK® MS, its MALDI-TOF1 Mass Spectrometry System for rapid pathogen identification, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded identification of mycobacteria, Nocardia and moulds. This database includes more than 15,000 distinct strains to provide extremely high accuracy and, for …

Read More

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® NECTAR (barium sulfate) Oral Suspension

By Healthcare Review
July 28, 2017
in :  News, North America

Bracco Diagnostics Inc. announced the U.S. Food and Drug Administration (FDA) approved VARIBAR NECTAR (barium sulfate) oral suspension for use in modified barium swallow (MBS) examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients with known or suspected swallowing disorders. Trouble with swallowing is a frequent cause of morbidity and disability in all age …

Read More

Cardinal Health announced that it has completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1 billion. The acquisition was funded with a combination of $4.5 billion in new senior unsecured notes, existing cash and borrowings under our existing credit arrangements. “This business provides our customers with more product offerings and includes some well-established brands that fit naturally within our portfolio and are complementary to our current medical products business. We know these products and many of the employees well, and have seen that our team members share a common commitment to quality, customer service and the patients who we all ultimately serve,” said George Barrett, chairman and CEO of Cardinal Health. “We are extremely excited about welcoming our new colleagues from around the world to Cardinal Health.” The Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business encompasses 23 product categories across multiple market sites of care, including numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo – brands used in nearly every U.S. hospital. The company also previously announced that it expects the acquisition to be accretive to non-GAAP¹ diluted earnings per share from continuing operations by more than $0.21 per share in fiscal 2018, net of incremental annual financing-related interest expense, and includes up to $100 million of inventory step-up costs during the first few quarters following closing. As previously disclosed, the company still expects the acquisition to be accretive to non-GAAP diluted earnings per share by more than $0.55 per share in fiscal 2019, and increasingly accretive thereafter. By the end of fiscal 2020, the company assumes synergies will exceed $150 million. The Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business will become part of Cardinal Health’s Medical segment, which is led by Don Casey, the segment’s chief executive officer. Integration efforts are off to a successful start and it is expected that all integration work and transitions will be completed over the next 18 months. Goldman, Sachs & Co. and Perella Weinberg Partners LP served as Cardinal Health’s financial advisors on this transaction, and Skadden, Arps, Slate, Meagher & Flom LLP and Jones Day served as its legal advisors.

By Healthcare Review
July 28, 2017
in :  Europe, News

TTP plc announces that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers. The new offering will include comprehensive product development services that span instrumentation, consumables and reagents. The partnership is focused on supporting customers in the molecular diagnostic and wider life science space to rapidly transition ideas into commercially successful products. The services will …

Read More

Agfa HealthCare Receives FDA 510(k) Clearance for Advanced Clinical Applications on XERO Universal Viewer

By Healthcare Review
July 27, 2017
in :  News, North America

Agfa HealthCare announces that it has received FDA 510(k) clearance for the XERO Xtend functionalities of the Enterprise Imaging zero-footprint viewer. XERO Xtend adds 3D processing and advanced clinical applications to the XERO Viewer. It is now FDA-cleared for diagnostic viewing on desktop devices.1 The release data for 510K cleared XERO Xtend will be communicated by Agfa HealthCare’s regional sales …

Read More
1...192021...33Page 20 of 33

Recent Posts

  • Houston Methodist Opens New State-Of-The-Art Patient Tower In Texas Medical Center
  • MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
  • NuVasive and Siemens Healthineers partner to transform spine surgery
  • Boston Scientific Announces Agreement to Acquire VENITI, Inc.
  • CHA-Hollywood Presbyterian Medical Center at the Forefront of Robotic Surgical Technology

Recent Comments

    Archives

    • August 2018
    • July 2018
    • June 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017

    Categories

    • Africa & Middle East
    • Asia
    • Europe
    • Featured Post
    • Industry Reports
    • News
    • North America
    • South America
    • Techno Trends

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    © Copyright 2016, All Rights Reserved Powered by WordPress | Designed by Bdaia